does not predict the ability of an assay to detect C. pneumoniae in tissues. We agree with Valassina et al. [1] that the presence of C. pneumoniae DNA alone in arterial specimens is insufficient proof of the presence of viable organisms in vascular tissue; however, cultural isolation of the bacterium from atherosclerotic plaques has been reported repeatedly [5, 6] . Furthermore, culture-derived data are in accordance with the results of our study on C. pneumoniae RNA in carotid plaques. Regarding the suggestion that inflammatory mechanisms such as molecular mimicry or induction of metabolic mechanisms are responsible for atheroma formation, rather than the presence of viable bacteria, we believe this to be partially true. However, the results of studies in animal models indicate that the presence of viable bacteria in vascular tissues is an essential element in the association between C. pneumoniae and development of atherosclerotic lesions [7] . To the Editor-In a recent study, we observed that homozygosity for an allelic variant of the chemokine gene SDF-1 (SDF1-3 A) was significantly associated with accelerated progression in advanced disease (i.e., from AIDS diagnosis until death) [1] . Since SDF-1 is the natural ligand of CXCR4, we investigated whether the SDF1-3 A/3 A effect was related to an increased prevalence of CXCR4-dependent human immunodeficiency virus (HIV) type 1 strains previously defined as syncytium-inducing (SI) viruses. Of interest, a switch from non-SI (NSI) to SI viruses, which are known to emerge in у50% of persons with advanced HIV-1 infection [2] , represents a correlate of faster disease progression, independent of viremia levels or CD4
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ϩ T cell counts [3] . The viral phenotype of primary viral isolates, as determined by standard infection of the MT-2 T cell line [3] , from 191 infected subjects randomly selected from the San Francisco Men's Health Study and from an additional 40 persons in the Milan cohort was available at 54-60 months of follow-up. Cox analysis on the survival rates of these subjects confirmed a strong protective effect of the NSI phenotype on disease progression; this remained significant after correction for HIV viremia levels, age, and antiretroviral therapy (relative hazard, 0.423; 95% confidence interval [CI], 0.289-0.621;
). However, no correlation was found P ! .0001 between SDF-1 genotype and viral phenotype.
In addition to SDF-1 and CCR5, an allelic variant of CCR2 (CCR2-64I), a gene encoding a receptor for the CC chemokine monocyte chemotactic protein (MCP)-1 through MCP-4, has been associated with a significant delay of disease progression in heterozygotes and homozygotes. Because CCR2 is rarely used as an entry coreceptor for HIV, the biologic correlate of CCR2-64I remains undefined, although linkage disequilibrium between the CCR2-64I and a mutation in the CCR5 promoter has been described [4] [5] [6] . Of interest, the presence of both CCR2 ϩ /64I and 64I/64I genotypes was associated with a significantly higher frequency of SI viruses than was observed in CCR2 ϩ / ϩ persons (table 1). As reported in some studies [7] , the CCR2-64I allele did not influence disease progression (RH, 1.02; 95% CI, 0.767-1.359; , Cox analysis), and no P p .888 significant differences in viremia levels were found among persons carrying different CCR2 alleles (not shown). In a previous study, infected persons carrying the CCR2-64I allele had a higher frequency of SI viruses, and the protective effect of this allele on disease progression was restricted to persons infected by NSI viruses [8] . In partial disagreement with these observations, the lack of protection from disease progression conferred by CCR2-64I was confirmed by separate Cox analysis of subjects infected with either NSI or SI viruses (RH, 1.105; 95% CI, 0.612-1.995;
, and RH, 0.889; 95% CI, 0.508-P p .74 1.555;
, respectively). P p .679 We speculate that factors linked to CCR2-64I might counterbalance the negative effect of SI viruses on disease progression. Heterologous desensitization of both CCR5 and CXCR4 by MCP-1 ligation and slightly lower CXCR4 expression on primary T cells from persons carrying CCR2-64I might play a role in HIV pathogenesis [6] . Finally, the observation that CCR2-64I is related to an increased frequency of SI HIV strains suggests a potential role of CCR2 ligands (i.e., MCPs) in the dynamics of HIV quasi species, in terms of chemokine coreceptor utilization. This hypothesis is supported by the observation that MCP-1 could up-regulate HIV replication [9] and favor the emergence of SI HIV strains in peripheral blood mononuclear cell cultures established from some HIV-infected persons [10] . 
